Ab Initio: BRIEF-Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies

* Ab Initio - addition of will somers, ph.d., vice president of biomedicines design at pfizer, to ab initio scientific advisory board